Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.23
-0.19 (-1.66%)
At close: Sep 12, 2025, 4:00 PM EDT
11.59
+0.36 (3.21%)
After-hours: Sep 12, 2025, 7:42 PM EDT

Greenwich LifeSciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
Selling, General & Admin
3.583.061.631.561.040.81
Upgrade
Research & Development
14.5612.957.76.483.561.06
Upgrade
Operating Expenses
18.1416.019.338.044.61.86
Upgrade
Operating Income
-18.14-16.01-9.33-8.04-4.6-1.86
Upgrade
Interest & Investment Income
0.150.220.440.220.030
Upgrade
Pretax Income
-17.99-15.79-8.89-7.83-4.57-1.86
Upgrade
Net Income
-17.99-15.79-8.89-7.83-4.57-1.86
Upgrade
Net Income to Common
-17.99-15.79-8.89-7.83-4.57-1.86
Upgrade
Shares Outstanding (Basic)
13131313139
Upgrade
Shares Outstanding (Diluted)
13131313139
Upgrade
Shares Change (YoY)
2.67%1.29%-0.51%-0.23%36.27%320.69%
Upgrade
EPS (Basic)
-1.36-1.21-0.69-0.61-0.35-0.20
Upgrade
EPS (Diluted)
-1.36-1.21-0.69-0.61-0.35-0.20
Upgrade
EBITDA
-18.14-16.01-9.32-8.04-4.59-1.86
Upgrade
D&A For EBITDA
000000
Upgrade
EBIT
-18.14-16.01-9.33-8.04-4.6-1.86
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q